Consumer Product Safety Commission September 2021 – Federal Register Recent Federal Regulation Documents

Notice of Prehearing Conference
Document Number: 2021-21224
Type: Notice
Date: 2021-09-30
Agency: Consumer Product Safety Commission, Agencies and Commissions
Notice of prehearing conference for In the Matter of Amazon.com, Inc.; CPSC Docket No. 21-2.
Safety Standard for Gates and Enclosures
Document Number: 2021-20851
Type: Rule
Date: 2021-09-28
Agency: Consumer Product Safety Commission, Agencies and Commissions
In July 2020, the U.S. Consumer Product Safety Commission (CPSC or Commission) published a consumer product safety standard for gates and enclosures under section 104 of the Consumer Product Safety Improvement Act of 2008 (CPSIA). The Commission's mandatory standard incorporated by reference the American Society for Testing and Materials (ASTM) voluntary standard that was in effect for gates and enclosures at the time, with modifications to make the standard more stringent, to further reduce the risk of injury associated with gates and enclosures. The CPSIA sets forth a process for updating mandatory standards for durable infant or toddler products that are based on a voluntary standard, when a voluntary standards organization revises the standard. In June 2021, ASTM published a revised voluntary standard for gates and enclosures, and it notified the Commission of this revised standard in July 2021. This direct final rule updates the mandatory standard for gates and enclosures to incorporate by reference ASTM's 2021 version of the voluntary standard for gates and enclosures.
Poison Prevention Packaging Requirements; Proposed Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More Than 80 mg of the Drug
Document Number: 2021-19953
Type: Proposed Rule
Date: 2021-09-16
Agency: Consumer Product Safety Commission, Agencies and Commissions
The Consumer Product Safety Commission (Commission or CPSC) is proposing to amend the child-resistant packaging requirements to exempt baloxavir marboxil tablets in packages containing not more than 80 mg of the drug, currently marketed as XOFLUZA,TM from the special packaging requirements. XOFLUZA is used to treat the flu, and is taken in one dose within 48 hours of experiencing flu symptoms. The proposed rule would exempt this prescription drug product on the basis that child-resistant packaging is not needed to protect young children from serious injury or illness because the product is not acutely toxic and lacks adverse human experience associated with ingestion.
Standard for the Flammability of Residential Upholstered Furniture
Document Number: 2021-19939
Type: Proposed Rule
Date: 2021-09-16
Agency: Consumer Product Safety Commission, Agencies and Commissions
The Consumer Product Safety Commission is withdrawing its proposed rule on flammability standards for residential upholstered furniture that published March 4, 2008 in the Federal Register. This rulemaking is no longer active because it has been superseded by the COVID-19 Regulatory Relief and Work From Home Safety Act.
Sunshine Act Meeting Notice
Document Number: 2021-19164
Type: Notice
Date: 2021-09-03
Agency: Consumer Product Safety Commission, Agencies and Commissions
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.